[1]
De, R. et al. 2022. A comparison of treatment outcomes for levofloxacin versus doxycycline plus metronidazole for first-line treatment of uncomplicated pelvic inflammatory disease. Asian Journal of Medical Sciences. 13, 12 (Dec. 2022), 179–184.